Medline ® Abstract for Reference 5
of 'Using scales to monitor symptoms and treat depression (measurement based care)'
5
TI
Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial.
AU
Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, McQuade RD, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M
SO
Psychiatr Serv. 2014;65(8):1058.
OBJECTIVE:
In this secondary analysis of results of the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial, patient behaviors that might account for the differences observed in clinical outcomes were examined.
METHODS:
Patients (N=914) diagnosed as having major depressive disorder participated in telephone interviews either monthly for six months (intervention) or at three and six months (usual care) asking about antidepressant medication-taking, use of psychotherapy or counseling, and participation in depression support groups. Physicians (N=83) in the intervention arm received monthly feedback regarding their patients' depression severity.
RESULTS:
A total of 664 (73%) patients completed the month 6 interview. The adjusted odds of current antidepressant use at six months were 85% greater (p=.01) for patients in the intervention (N=380) versus usual care (N=284) arms, according to multivariate regression analyses.
CONCLUSIONS:
More frequent measurement of depression symptoms was associated with greater medication persistence, which in turn may have mediated clinical improvements.
AD
PMID